New Releases


Webcast ImageWebcast
Optinose Q3 2018 Earnings Conference Call (Replay)
11/13/18 at 8:00 a.m. ET
Optinose Q3 2018 Earnings Conference Call
Tuesday, November 13, 2018 8:00 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Webcast ImageWebcast
Optinose Jefferies 2018 London Healthcare Conference  (Replay)
11/15/18 at 3:00 a.m. ET
Optinose Jefferies 2018 London Healthcare Conference
Thursday, November 15, 2018 3:00 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Webcast ImageWebcast
Optinose at the 30th Annual Piper Jaffray Healthcare Conference (Live)
11/27/18 at 1:30 p.m. ET
Optinose at the 30th Annual Piper Jaffray Healthcare Conference
Tuesday, November 27, 2018 1:30 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Keyword Search
 
2018 | 2017 | 2016 | 2015 | 2014
DateTitle 
11/13/18Optinose Reports Third Quarter 2018 Financial Results and Recent Operational HighlightsPrinter Friendly Version
10/31/18Optinose to Report Third Quarter 2018 Financial Results and Corporate Updates on November 13, 2018Printer Friendly Version
10/03/18Optinose to Highlight Data at Two Upcoming Scientific MeetingsPrinter Friendly Version
09/24/18Optinose to Present at the 2018 Cantor Global Healthcare ConferencePrinter Friendly Version
08/14/18Optinose Reports Second Quarter 2018 Financial Results and Recent Operational HighlightsPrinter Friendly Version
08/07/18Optinose to Report Second Quarter 2018 Financial Results and Corporate Updates on August 14, 2018Printer Friendly Version
07/02/18Optinose Named a 2018 Best Place to Work by Philadelphia Business JournalPrinter Friendly Version
06/21/18Optinose Announces Publication of Pivotal Efficacy and Long-Term Safety Data for XHANCE in Peer Reviewed JournalsPrinter Friendly Version
06/15/18Optinose CEO Peter Miller and President and COO Ramy Mahmoud Named EY Life Sciences Entrepreneur Of The Year 2018 in GreaterPrinter Friendly Version
06/11/18Optinose Announces Closing of Public Offering and Exercise in Full of the Underwriters' Option to Purchase Additional Common SharesPrinter Friendly Version
06/06/18Optinose Announces Pricing of Public Offering of Common StockPrinter Friendly Version
06/04/18Optinose Announces Launch of Public Offering of Common StockPrinter Friendly Version
05/14/18Optinose Reports First Quarter 2018 Financial Results and Recent Operational HighlightsPrinter Friendly Version
05/07/18Optinose to Report First Quarter 2018 Financial Results and Corporate Updates on May 14, 2018Printer Friendly Version
04/23/18Optinose CEO Peter Miller and President/COO Ramy Mahmoud Named EY Entrepreneur of the Year 2018 Finalists in the Greater Philadelphia AreaPrinter Friendly Version
03/15/18Optinose Named Emerging Company of the Year by Life Sciences PennsylvaniaPrinter Friendly Version
03/13/18Optinose Reports Fourth Quarter and Full Year 2017 Financial Results and Recent Operational HighlightsPrinter Friendly Version
03/06/18Optinose to Report Fourth Quarter and Full Year 2017 Financial Results and Corporate Updates on March 13, 2018Printer Friendly Version
02/27/18Optinose to Highlight Data at the 2018 AAAAI/WAO Joint CongressPrinter Friendly Version
02/22/18Optinose names Sandra L. Helton as Director and Chairperson of the Company’s Audit CommitteePrinter Friendly Version
02/20/18Peter Miller Named Frank Baldino Bioscience CEO of the Year by Life Sciences PennsylvaniaPrinter Friendly Version
02/15/18Optinose to Present at the 2018 RBC Capital Markets Healthcare ConferencePrinter Friendly Version
02/09/18Optinose to Present at Leerink Partners 7th Annual Global Healthcare ConferencePrinter Friendly Version
01/02/18Optinose Announces $100 Million Debt Financing from Athyrium Capital ManagementPrinter Friendly Version